Making more COVID-19 vaccines available to address global needs: Considerations and a framework for their evaluation
Vaccine
.
2022 Sep 22;40(40):5749-5751.
doi: 10.1016/j.vaccine.2022.07.028.
Epub 2022 Jul 26.
Authors
Philip R Krause
1
,
Narendra Arora
2
,
William Dowling
3
,
César Muñoz-Fontela
4
,
Simon Funnell
5
,
Rogerio Gaspar
6
,
Marion F Gruber
7
,
Adam Hacker
3
,
Ana Maria Henao-Restrepo
6
,
Stanley Plotkin
8
,
Helen V Rees
9
,
Dean K Smith
10
,
Soumya Swaminathan
6
Affiliations
1
World Health Organization, Geneva, Switzerland. Electronic address:
[email protected]
.
2
The Inclen Trust International, New Delhi, India.
3
Coalition for Epidemic Preparedness Innovations, Oslo, Norway.
4
Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
5
United Kingdom Health Security Agency, Salisbury SP4 0JG, UK; Quadram Institute Bioscience, Norwich NR4 7UQ, UK; World Health Organization, Avenue Appia 20, 1211 Geneva 27, Switzerland.
6
World Health Organization, Avenue Appia 20, 1211 Geneva 27, Switzerland.
7
International AIDS Vaccine Initiative, New York, NY 10004, USA.
8
University of Pennsylvania, Philadelphia, PA, USA.
9
South African Health Products Regulatory Authority and Wits RHI, University of the Witwatersrand, South Africa.
10
Centre for Biologics Evaluation, Biologics and Radiopharmaceutical Drugs Directorate, Health Canada, Ottawa, ON, Canada.
PMID:
35941036
PMCID:
PMC9343170
DOI:
10.1016/j.vaccine.2022.07.028
No abstract available
MeSH terms
COVID-19 Vaccines
COVID-19* / prevention & control
Humans
SARS-CoV-2
Vaccines*
Viral Vaccines*
Substances
COVID-19 Vaccines
Vaccines
Viral Vaccines
Grants and funding
001/WHO_/World Health Organization/International